Pharvaris (PHVS) Other Operating Expenses (2021 - 2026)

Pharvaris' (PHVS) quarterly Other Operating Expenses came in at -$0.0 in Q3 2025, up 100.0% on a QoQ basis from -$67.0 million in Q2 2025.

Analysis

Pharvaris (PHVS) Other Operating Expenses (2021 - 2026) Analysis & Trends

Pharvaris (PHVS) has 5 years of Other Operating Expenses data on file, last reported at -$0.0 in Q3 2025.

Peer Set

#	Company	Market Cap	Enterprise Value	Gross Profit (Qtr)
1	Vertex Pharmaceuticals	139.62 Bn	131.77 Bn	2.84 Bn
2	Regeneron Pharmaceuticals	85.73 Bn	77.73 Bn	3.93 Bn
3	Argenx Se	63.53 Bn	58.35 Bn	1.37 Bn
4	Moderna	58.23 Bn	53.09 Bn	52.00 Mn
5	Revolution Medicines	44.05 Bn	44.05 Bn	-
6	BeOne Medicines	40.03 Bn	34.93 Bn	1.53 Bn
7	Alnylam Pharmaceuticals	35.50 Bn	32.19 Bn	992.69 Mn
8	Royalty Pharma	28.52 Bn	27.68 Bn	-
9	Insmed	27.46 Bn	26.30 Bn	358.27 Mn
10	Pharvaris	2.14 Bn	1.77 Bn	85,072.10

Historic Data

Download Data